Fundraising FoxInkef — 2026 Investments
3 investments dated 2026 · listed companies and verified rows first · show all
Kinaset Therapeutics is a drug developer working on KN-002, a therapeutic candidate for treating severe asthma across patients regardless of the underlying cause of inflammation.
BiotechHealthtechMedfield, US
Roger Heerman(Chief Business/Operating Officer / Co-Founder)inFrazer Morgan(Chief Development Officer / Co-Founder)inRobert Clarke(Chief Executive Officer / Board Member / Co-Founder)Christopher O’Brien(Chief Medical Officer)
BoardJamil Beg(Director of the Issuer)inTom King(Director of the Issuer)
Co-investors5AM VenturesAtlas VentureRA CapitalEQT Life SciencesGimvSixty Degree Capital+3 more
Quantum operates an omnichannel advertising technology platform that connects online and offline retail media, letting retailers, brands, and agencies trade and exchange media across the commerce ecosystem.
AdTechData & InfrastructureMarketing TechMedia & EntertainmentRetail Tech
Omar MalaikahinSara Bin Ladin
Co-investors500 GlobalTech Invest ComDCVC (Data Collective)Lansdowne PartnersS3 VenturesSpeciale Invest
Quantum Motion develops utility-scale quantum computers built on silicon-spin architecture, using standard silicon processing compatible with existing semiconductor foundries and designed to fit into data centres.
Deep TechQuantum ComputingSemiconductors
John Morton(Founder)Simon Benjamin(Founder)
Co-investorsMundi VenturesBosch VenturesBritish Business BankDCVC (Data Collective)IP GroupLansdowne Partners+2 more
Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.